0000897069-15-000162.txt : 20150218 0000897069-15-000162.hdr.sgml : 20150218 20150218100116 ACCESSION NUMBER: 0000897069-15-000162 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150218 DATE AS OF CHANGE: 20150218 EFFECTIVENESS DATE: 20150218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Reven Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001556231 IRS NUMBER: 000000000 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-212162 FILM NUMBER: 15626413 BUSINESS ADDRESS: STREET 1: 4411 BEE RIDGE ROAD STREET 2: SUITE 285 CITY: SARASOTA STATE: FL ZIP: 34233 BUSINESS PHONE: 941-320-9271 MAIL ADDRESS: STREET 1: 4411 BEE RIDGE ROAD STREET 2: SUITE 285 CITY: SARASOTA STATE: FL ZIP: 34233 D/A 1 primary_doc.xml X0707 D/A LIVE 0001556231 Reven Pharmaceuticals, Inc. 4411 BEE RIDGE ROAD SUITE 285 SARASOTA FL FLORIDA 34233 941-320-9271 FLORIDA Advanced Diagnostics International of Florida, Inc. Noventis, Inc. None Corporation true Peter B. Lange 4411 Bee Ridge Road Suite 285 Sarasota FL FLORIDA 34233 Executive Officer Director Brian Denomme 4411 Bee Ridge Road Suite 285 Sarasota FL FLORIDA 34233 Executive Officer Director Michael Handley 4411 Bee Ridge Road Suite 285 Sarasota FL FLORIDA 34233 Executive Officer Michael A. Volk 4411 Bee Ridge Road Suite 285 Sarasota FL FLORIDA 34233 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0000897069-14-000156 2014-01-08 true true false 50000 7000000 4440594 2559406 false 48 0 0 850000 true This estimate reflects the maximum amount to be used for management and personnel costs if Total Offering Amount raised. false Reven Pharmaceuticals, Inc. Michael A. Volk Michael A. Volk Chief Administrative Officer 2015-02-17